APO Research
Talk to an analyst

APO RESEARCH · REPORT

Split Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Split Influenza Vaccine Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchSplit Influenza Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Split Influenza Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Split Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Split Influenza Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Split Influenza Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Split Influenza Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Split Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Split Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Split Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Split Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Split Influenza Vaccine include CSL Seqirus, Seqirus, Inc., straZeneca, Dalian Yali Peak, GSK and Sanofi Pasteur, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Split Influenza Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Split Influenza Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Split Influenza Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Split Influenza Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Split Influenza Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Split Influenza Vaccine sales, projected growth trends, production technology, application and end-user industry.

Split Influenza Vaccine Segment by Company

CSL Seqirus

Seqirus, Inc.

straZeneca

Dalian Yali Peak

GSK

Sanofi Pasteur

Split Influenza Vaccine Segment by Type

Aldult

Child

Split Influenza Vaccine Segment by Application

Hospital

Clinic

Split Influenza Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Split Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Split Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Split Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Split Influenza Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Split Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Split Influenza Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Split Influenza Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Aldult Major Manufacturers Table 3. Child Major Manufacturers Table 4. Global Split Influenza Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Split Influenza Vaccine Industry Trends Table 8. Split Influenza Vaccine Industry Drivers Table 9. Split Influenza Vaccine Industry Opportunities and Challenges Table 10. Split Influenza Vaccine Industry Restraints Table 11. Global Split Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Split Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Split Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Split Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Split Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Split Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Split Influenza Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global Split Influenza Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global Split Influenza Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Split Influenza Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Split Influenza Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Split Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Split Influenza Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Split Influenza Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Split Influenza Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Split Influenza Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Split Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Split Influenza Vaccine Manufacturers, Product Type & Application Table 29. Global Split Influenza Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Split Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Split Influenza Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Split Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Split Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Split Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Split Influenza Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Split Influenza Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global Split Influenza Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global Split Influenza Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Split Influenza Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Split Influenza Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global Split Influenza Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global Split Influenza Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Split Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Split Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Split Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Split Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Split Influenza Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Split Influenza Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global Split Influenza Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global Split Influenza Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Split Influenza Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Split Influenza Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global Split Influenza Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. CSL Seqirus Company Information Table 57. CSL Seqirus Business Overview Table 58. CSL Seqirus Split Influenza Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. CSL Seqirus Split Influenza Vaccine Product Portfolio Table 60. CSL Seqirus Recent Development Table 61. Seqirus, Inc. Company Information Table 62. Seqirus, Inc. Business Overview Table 63. Seqirus, Inc. Split Influenza Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Seqirus, Inc. Split Influenza Vaccine Product Portfolio Table 65. Seqirus, Inc. Recent Development Table 66. straZeneca Company Information Table 67. straZeneca Business Overview Table 68. straZeneca Split Influenza Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. straZeneca Split Influenza Vaccine Product Portfolio Table 70. straZeneca Recent Development Table 71. Dalian Yali Peak Company Information Table 72. Dalian Yali Peak Business Overview Table 73. Dalian Yali Peak Split Influenza Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Dalian Yali Peak Split Influenza Vaccine Product Portfolio Table 75. Dalian Yali Peak Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Split Influenza Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. GSK Split Influenza Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Sanofi Pasteur Company Information Table 82. Sanofi Pasteur Business Overview Table 83. Sanofi Pasteur Split Influenza Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur Split Influenza Vaccine Product Portfolio Table 85. Sanofi Pasteur Recent Development Table 86. North America Split Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Split Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Split Influenza Vaccine Sales by Type (2021-2026) & (k units) Table 89. North America Split Influenza Vaccine Sales by Type (2027-2032) & (k units) Table 90. North America Split Influenza Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 91. North America Split Influenza Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 92. North America Split Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Split Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Split Influenza Vaccine Sales by Application (2021-2026) & (k units) Table 95. North America Split Influenza Vaccine Sales by Application (2027-2032) & (k units) Table 96. North America Split Influenza Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 97. North America Split Influenza Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 98. North America Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Split Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Split Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 102. North America Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 103. North America Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 104. North America Split Influenza Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 105. North America Split Influenza Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 106. United States Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 107. Canada Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 108. Mexico Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 109. Europe Split Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Split Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Split Influenza Vaccine Sales by Type (2021-2026) & (k units) Table 112. Europe Split Influenza Vaccine Sales by Type (2027-2032) & (k units) Table 113. Europe Split Influenza Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 114. Europe Split Influenza Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 115. Europe Split Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Split Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Split Influenza Vaccine Sales by Application (2021-2026) & (k units) Table 118. Europe Split Influenza Vaccine Sales by Application (2027-2032) & (k units) Table 119. Europe Split Influenza Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 120. Europe Split Influenza Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 121. Europe Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Split Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Split Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 125. Europe Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 126. Europe Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 127. Europe Split Influenza Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 128. Europe Split Influenza Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 129. Germany Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 130. France Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 131. U.K. Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 132. Italy Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 133. Russia Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 134. Spain Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 137. Sweden Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 138. Poland Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 139. China Split Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 140. China Split Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 141. China Split Influenza Vaccine Sales by Type (2021-2026) & (k units) Table 142. China Split Influenza Vaccine Sales by Type (2027-2032) & (k units) Table 143. China Split Influenza Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 144. China Split Influenza Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 145. China Split Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 146. China Split Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 147. China Split Influenza Vaccine Sales by Application (2021-2026) & (k units) Table 148. China Split Influenza Vaccine Sales by Application (2027-2032) & (k units) Table 149. China Split Influenza Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 150. China Split Influenza Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 151. Asia Split Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Split Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Split Influenza Vaccine Sales by Type (2021-2026) & (k units) Table 154. Asia Split Influenza Vaccine Sales by Type (2027-2032) & (k units) Table 155. Asia Split Influenza Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 156. Asia Split Influenza Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 157. Asia Split Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Split Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Split Influenza Vaccine Sales by Application (2021-2026) & (k units) Table 160. Asia Split Influenza Vaccine Sales by Application (2027-2032) & (k units) Table 161. Asia Split Influenza Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 162. Asia Split Influenza Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 163. Asia Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Split Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Split Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 167. Asia Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 168. Asia Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 169. Asia Split Influenza Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 170. Asia Split Influenza Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 171. Japan Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 172. South Korea Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 173. India Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 174. Australia Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Split Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Split Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Split Influenza Vaccine Sales by Type (2021-2026) & (k units) Table 180. SAMEA Split Influenza Vaccine Sales by Type (2027-2032) & (k units) Table 181. SAMEA Split Influenza Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 182. SAMEA Split Influenza Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 183. SAMEA Split Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Split Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Split Influenza Vaccine Sales by Application (2021-2026) & (k units) Table 186. SAMEA Split Influenza Vaccine Sales by Application (2027-2032) & (k units) Table 187. SAMEA Split Influenza Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 188. SAMEA Split Influenza Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 189. SAMEA Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Split Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Split Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 193. SAMEA Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 194. SAMEA Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 195. SAMEA Split Influenza Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 196. SAMEA Split Influenza Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 197. Brazil Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Argentina Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 199. Chile Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Colombia Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 201. Peru Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Israel Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 204. UAE Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Turkey Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Iran Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Egypt Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Split Influenza Vaccine Distributors List Table 211. Split Influenza Vaccine Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Split Influenza Vaccine Image Figure 2. Global Split Influenza Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Split Influenza Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Aldult Image Figure 5. Child Image Figure 6. Global Split Influenza Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Split Influenza Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Split Influenza Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Split Influenza Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Split Influenza Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Split Influenza Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Split Influenza Vaccine Sales (2021-2032) & (k units) Figure 16. Global Split Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Split Influenza Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Split Influenza Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe Split Influenza Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China Split Influenza Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Split Influenza Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Split Influenza Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global Split Influenza Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Split Influenza Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Split Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Split Influenza Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Split Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Split Influenza Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Split Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Split Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Split Influenza Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Split Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Split Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Split Influenza Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Split Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Split Influenza Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Split Influenza Vaccine Sales Share by Type (2021-2032) Figure 40. North America Split Influenza Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Split Influenza Vaccine Sales Share by Application (2021-2032) Figure 42. North America Split Influenza Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Split Influenza Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Split Influenza Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Split Influenza Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Split Influenza Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Split Influenza Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Split Influenza Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Split Influenza Vaccine Sales Share by Country (2021-2032) Figure 50. China Split Influenza Vaccine Revenue Share by Type (2021-2032) Figure 51. China Split Influenza Vaccine Sales Share by Type (2021-2032) Figure 52. China Split Influenza Vaccine Revenue Share by Application (2021-2032) Figure 53. China Split Influenza Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Split Influenza Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Split Influenza Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Split Influenza Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Split Influenza Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Split Influenza Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Split Influenza Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Split Influenza Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Split Influenza Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Split Influenza Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Split Influenza Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Split Influenza Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Split Influenza Vaccine Sales Share by Country (2021-2032) Figure 66. Split Influenza Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Split Influenza Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Aldult
  • Child
Applications
  • Hospital
  • Clinic
Companies covered
  • CSL Seqirus
  • Seqirus, Inc.
  • straZeneca
  • Dalian Yali Peak
  • GSK
  • Sanofi Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Split Influenza Vaccine Market by Type
  3. 1.2.1 Global Split Influenza Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Aldult
  5. 1.2.3 Child
  6. 1.3 Split Influenza Vaccine Market by Application
  7. 1.3.1 Global Split Influenza Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Split Influenza Vaccine Market Dynamics
  1. 2.1 Split Influenza Vaccine Industry Trends
  2. 2.2 Split Influenza Vaccine Industry Drivers
  3. 2.3 Split Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Split Influenza Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Split Influenza Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Split Influenza Vaccine Revenue by Region
  3. 3.2.1 Global Split Influenza Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Split Influenza Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Split Influenza Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Split Influenza Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Split Influenza Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Split Influenza Vaccine Sales by Region
  9. 3.4.1 Global Split Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Split Influenza Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Split Influenza Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Split Influenza Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Split Influenza Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Split Influenza Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Split Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Split Influenza Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Split Influenza Vaccine Sales by Manufacturers
  6. 4.2.1 Global Split Influenza Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Split Influenza Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Split Influenza Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Split Influenza Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Split Influenza Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Split Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Split Influenza Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Split Influenza Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Split Influenza Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Split Influenza Vaccine Tier 1, Tier 2, and Tier 3
5 Split Influenza Vaccine Market by Type
  1. 5.1 Global Split Influenza Vaccine Revenue by Type
  2. 5.1.1 Global Split Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Split Influenza Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Split Influenza Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Split Influenza Vaccine Sales by Type
  6. 5.2.1 Global Split Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Split Influenza Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Split Influenza Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Split Influenza Vaccine Price by Type
6 Split Influenza Vaccine Market by Application
  1. 6.1 Global Split Influenza Vaccine Revenue by Application
  2. 6.1.1 Global Split Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Split Influenza Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Split Influenza Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Split Influenza Vaccine Sales by Application
  6. 6.2.1 Global Split Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Split Influenza Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Split Influenza Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Split Influenza Vaccine Price by Application
7 Company Profiles
  1. 7.1 CSL Seqirus
  2. 7.1.1 CSL Seqirus Company Information
  3. 7.1.2 CSL Seqirus Business Overview
  4. 7.1.3 CSL Seqirus Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSL Seqirus Split Influenza Vaccine Product Portfolio
  6. 7.1.5 CSL Seqirus Recent Developments
  7. 7.2 Seqirus, Inc.
  8. 7.2.1 Seqirus, Inc. Company Information
  9. 7.2.2 Seqirus, Inc. Business Overview
  10. 7.2.3 Seqirus, Inc. Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Seqirus, Inc. Split Influenza Vaccine Product Portfolio
  12. 7.2.5 Seqirus, Inc. Recent Developments
  13. 7.3 straZeneca
  14. 7.3.1 straZeneca Company Information
  15. 7.3.2 straZeneca Business Overview
  16. 7.3.3 straZeneca Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 straZeneca Split Influenza Vaccine Product Portfolio
  18. 7.3.5 straZeneca Recent Developments
  19. 7.4 Dalian Yali Peak
  20. 7.4.1 Dalian Yali Peak Company Information
  21. 7.4.2 Dalian Yali Peak Business Overview
  22. 7.4.3 Dalian Yali Peak Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Dalian Yali Peak Split Influenza Vaccine Product Portfolio
  24. 7.4.5 Dalian Yali Peak Recent Developments
  25. 7.5 GSK
  26. 7.5.1 GSK Company Information
  27. 7.5.2 GSK Business Overview
  28. 7.5.3 GSK Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GSK Split Influenza Vaccine Product Portfolio
  30. 7.5.5 GSK Recent Developments
  31. 7.6 Sanofi Pasteur
  32. 7.6.1 Sanofi Pasteur Company Information
  33. 7.6.2 Sanofi Pasteur Business Overview
  34. 7.6.3 Sanofi Pasteur Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Pasteur Split Influenza Vaccine Product Portfolio
  36. 7.6.5 Sanofi Pasteur Recent Developments
8 North America
  1. 8.1 North America Split Influenza Vaccine Market Size by Type
  2. 8.1.1 North America Split Influenza Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Split Influenza Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Split Influenza Vaccine Price by Type (2021-2032)
  5. 8.2 North America Split Influenza Vaccine Market Size by Application
  6. 8.2.1 North America Split Influenza Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Split Influenza Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Split Influenza Vaccine Price by Application (2021-2032)
  9. 8.3 North America Split Influenza Vaccine Market Size by Country
  10. 8.3.1 North America Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Split Influenza Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Split Influenza Vaccine Market Size by Type
  2. 9.1.1 Europe Split Influenza Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Split Influenza Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Split Influenza Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Split Influenza Vaccine Market Size by Application
  6. 9.2.1 Europe Split Influenza Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Split Influenza Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Split Influenza Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Split Influenza Vaccine Market Size by Country
  10. 9.3.1 Europe Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Split Influenza Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Split Influenza Vaccine Market Size by Type
  2. 10.1.1 China Split Influenza Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Split Influenza Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Split Influenza Vaccine Price by Type (2021-2032)
  5. 10.2 China Split Influenza Vaccine Market Size by Application
  6. 10.2.1 China Split Influenza Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Split Influenza Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Split Influenza Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Split Influenza Vaccine Market Size by Type
  2. 11.1.1 Asia Split Influenza Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Split Influenza Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Split Influenza Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Split Influenza Vaccine Market Size by Application
  6. 11.2.1 Asia Split Influenza Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Split Influenza Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Split Influenza Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Split Influenza Vaccine Market Size by Country
  10. 11.3.1 Asia Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Split Influenza Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Split Influenza Vaccine Market Size by Type
  2. 12.1.1 SAMEA Split Influenza Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Split Influenza Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Split Influenza Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Split Influenza Vaccine Market Size by Application
  6. 12.2.1 SAMEA Split Influenza Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Split Influenza Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Split Influenza Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Split Influenza Vaccine Market Size by Country
  10. 12.3.1 SAMEA Split Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Split Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Split Influenza Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Split Influenza Vaccine Value Chain Analysis
  2. 13.1.1 Split Influenza Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Split Influenza Vaccine Production Mode & Process
  6. 13.2 Split Influenza Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Split Influenza Vaccine Distributors
  9. 13.2.3 Split Influenza Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst